Morning Briefing
Summaries of health policy coverage from major news organizations
Supreme Court To Hear Case About 'Pay To Delay' Deals Between Generic And Branded Drug Makers
Generic and the brand-name drug companies -- usually fierce competitors -- will be on the same side as they argue their case against the federal government. At issue is whether brand name drug manufacturers may pay generics to keep generic competitors off the market.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
